---
title: "Goserelin - Endometriosis"
sidebar: mydoc_sidebar
permalink: db00014-mesh-d004715-1.html
toc: false 
---


Path ID: `DB00014_MESH_D004715_1`
{% include image.html url="images/db00014-mesh-d004715-1.png" file="db00014-mesh-d004715-1.png" alt="db00014-mesh-d004715-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D017273 | Goserelin | Drug |
| UniProt:P30968 | Gonadotropin releasing hormone (GnRH) receptors | Protein |
| MESH:D011374 | Progesterone | ChemicalSubstance |
| UBERON:0000007 | Pituitary | GrossAnatomicalStructure |
| GO:0032274 | Gonadotropin secretion | BiologicalProcess |
| MESH:D004958 | Estradiol | ChemicalSubstance |
| MESH:D004715 | Endometriosis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Goserelin | INCREASES ACTIVITY OF | Gonadotropin Releasing Hormone (Gnrh) Receptors |
| Gonadotropin Releasing Hormone (Gnrh) Receptors | LOCATED IN | Pituitary |
| Pituitary | NEGATIVELY REGULATES | Gonadotropin Secretion |
| Gonadotropin Secretion | DECREASES ABUNDANCE OF | Estradiol |
| Estradiol | MANIFESTATION OF | Endometriosis |
| Gonadotropin Secretion | DECREASES ABUNDANCE OF | Progesterone |
| Progesterone | MANIFESTATION OF | Endometriosis |
|---------|-----------|---------|

Comment: Goserelin is a synthetic hormone

Reference: 
  - [https://go.drugbank.com/drugs/DB00014#mechanismofaction](https://go.drugbank.com/drugs/DB00014#mechanismofaction)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Goserelin#section=Pharmacology-and-Biochemistry](https://pubchem.ncbi.nlm.nih.gov/compound/Goserelin#section=Pharmacology-and-Biochemistry)
  - [http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Goserelin_monograph_1Aug2012_formatted.pdf](http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Goserelin_monograph_1Aug2012_formatted.pdf)
